Bayer, MOMA collaborate on small molecule oncology programme
MOMA will receive an upfront payment and collaboration fee and is eligible to receive near-term discovery, development, and commercial milestones as well as tiered royalties on net sales
AstraZeneca licenses CSPC’s pre-clinical lipoprotein disruptor
Innovent to commercialise Ask Pharm’s lung cancer drug in China
Johnson & Johnson halts Phase 3 SunRISe-2 trial of TAR-200 in MIBC
Novo Nordisk and Mylan settle US patent battles for Ozempic and Wegovy
Pharmanovia acquires exclusive rights to treatment for parkinson’s disease
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry